These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 7486483)

  • 1. Ribavirin as therapy for chronic hepatitis C. A randomized, double-blind, placebo-controlled trial.
    Di Bisceglie AM; Conjeevaram HS; Fried MW; Sallie R; Park Y; Yurdaydin C; Swain M; Kleiner DE; Mahaney K; Hoofnagle JH
    Ann Intern Med; 1995 Dec; 123(12):897-903. PubMed ID: 7486483
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation of serum HCV RNA and alanine aminotransferase levels in chronic hepatitis C patients during treatment with ribavirin.
    Tong MJ; Hwang SJ; Lefkowitz M; Lee SD; Co RL; Conrad A; Schmid P; Lo KJ
    J Gastroenterol Hepatol; 1994; 9(6):587-91. PubMed ID: 7865717
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ribavirin treatment for patients with chronic hepatitis C: results of a placebo-controlled study.
    Dusheiko G; Main J; Thomas H; Reichard O; Lee C; Dhillon A; Rassam S; Fryden A; Reesink H; Bassendine M; Norkrans G; Cuypers T; Lelie N; Telfer P; Watson J; Weegink C; Sillikens P; Weiland O
    J Hepatol; 1996 Nov; 25(5):591-8. PubMed ID: 8938532
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effects of supplementation with the antioxidant flavonoid, silymarin, in chronic hepatitis C patients treated with peg-interferon + ribavirin. A placebo-controlled double blind study].
    Pár A; Roth E; Miseta A; Hegedüs G; Pár G; Hunyady B; Vincze A
    Orv Hetil; 2009 Jan; 150(2):73-9. PubMed ID: 19103558
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long term histological improvement and clearance of intrahepatic hepatitis C virus RNA following sustained response to interferon-ribavirin combination therapy in liver transplanted patients with hepatitis C virus recurrence.
    Bizollon T; Ahmed SN; Radenne S; Chevallier M; Chevallier P; Parvaz P; Guichard S; Ducerf C; Baulieux J; Zoulim F; Trepo C
    Gut; 2003 Feb; 52(2):283-7. PubMed ID: 12524414
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interferon alfa-2b alone or in combination with ribavirin for the treatment of relapse of chronic hepatitis C. International Hepatitis Interventional Therapy Group.
    Davis GL; Esteban-Mur R; Rustgi V; Hoefs J; Gordon SC; Trepo C; Shiffman ML; Zeuzem S; Craxi A; Ling MH; Albrecht J
    N Engl J Med; 1998 Nov; 339(21):1493-9. PubMed ID: 9819447
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Maintenance therapy with ribavirin in patients with chronic hepatitis C who fail to respond to combination therapy with interferon alfa and ribavirin.
    Hoofnagle JH; Ghany MG; Kleiner DE; Doo E; Heller T; Promrat K; Ong J; Khokhar F; Soza A; Herion D; Park Y; Everhart JE; Liang TJ
    Hepatology; 2003 Jul; 38(1):66-74. PubMed ID: 12829988
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prolonged therapy of chronic hepatitis C with ribavirin.
    Hoofnagle JH; Lau D; Conjeevaram H; Kleiner D; Di Bisceglie AM
    J Viral Hepat; 1996 Sep; 3(5):247-52. PubMed ID: 8914004
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Volunteer blood donors with antibody to hepatitis C virus: clinical, biochemical, virologic, and histologic features. The Hepatitis C Study Group.
    Shakil AO; Conry-Cantilena C; Alter HJ; Hayashi P; Kleiner DE; Tedeschi V; Krawczynski K; Conjeevaram HS; Sallie R; Di Bisceglie AM
    Ann Intern Med; 1995 Sep; 123(5):330-7. PubMed ID: 7542854
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical presentation, outcome, and response to therapy among patients with acute exacerbation of chronic hepatitis C.
    Sagnelli E; Pisaturo M; Stanzione M; Messina V; Alessio L; Sagnelli C; Starace M; Pasquale G; Coppola N
    Clin Gastroenterol Hepatol; 2013 Sep; 11(9):1174-1180.e11. PubMed ID: 23591280
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pilot study of the combination of interferon alfa and ribavirin as therapy of recurrent hepatitis C after liver transplantation.
    Bizollon T; Palazzo U; Ducerf C; Chevallier M; Elliott M; Baulieux J; Pouyet M; Trepo C
    Hepatology; 1997 Aug; 26(2):500-4. PubMed ID: 9252166
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis C viral RNA titers in serum prior to, during, and after oral treatment with ribavirin for chronic hepatitis C.
    Reichard O; Yun ZB; Sönnerborg A; Weiland O
    J Med Virol; 1993 Oct; 41(2):99-102. PubMed ID: 8283183
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tolerance and efficacy of oral ribavirin treatment of chronic hepatitis C: a multicenter trial.
    Bodenheimer HC; Lindsay KL; Davis GL; Lewis JH; Thung SN; Seeff LB
    Hepatology; 1997 Aug; 26(2):473-7. PubMed ID: 9252161
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of response to combined interferon alpha-2b and ribavirin therapy in patients of chronic hepatitis c with serum alanine aminotransferase levels and severity of the disease on liver biopsy.
    Nadeem A; Hussain MM; Aslam M; Hussain T; Butt IF; Ali Khan S; Asad A
    J Ayub Med Coll Abbottabad; 2009; 21(2):103-6. PubMed ID: 20524482
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ribavirin/interferon-alpha sequential treatment of recurrent hepatitis C after liver transplantation.
    Giostra E; Kullak-Ublick GA; Keller W; Fried R; Vanlemmens C; Kraehenbuhl S; Locher S; Egger HP; Clavien PA; Hadengue A; Mentha G; Morel P; Negro F
    Transpl Int; 2004 May; 17(4):169-76. PubMed ID: 15060764
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early HCV RNA changes in patients with chronic hepatitis C treated with peginterferon alfa 2b and ribavirin.
    Gallegos-Orozco JF; Fuentes AP; Olivera-Martinez MA; Gutiérrez-Reyes G; Cortina D; Oregel JA; Pérez-Pruna C; Sixtos MS; Cruz-Castellanos S; Soto-Ramírez LE; Rodríguez-Díaz R; Fuentes-Romero L; Gutiérrez-Ruiz MC; Kershenobich D
    Rev Invest Clin; 2003; 55(2):138-42. PubMed ID: 12827916
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polyunsaturated phosphatidyl-choline and interferon alpha for treatment of chronic hepatitis B and C: a multi-center, randomized, double-blind, placebo-controlled trial. Leich Study Group.
    Niederau C; Strohmeyer G; Heintges T; Peter K; Göpfert E
    Hepatogastroenterology; 1998; 45(21):797-804. PubMed ID: 9684137
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Acute hepatitis C: response to treatment with interferon-alpha plus ribavirin].
    Vega Palomares R; Planas Vilà R; Durández Lazaro R; Fábregas Puigtió S
    Gastroenterol Hepatol; 2002 Oct; 25(8):483-6. PubMed ID: 12361528
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group.
    McHutchison JG; Gordon SC; Schiff ER; Shiffman ML; Lee WM; Rustgi VK; Goodman ZD; Ling MH; Cort S; Albrecht JK
    N Engl J Med; 1998 Nov; 339(21):1485-92. PubMed ID: 9819446
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A prospective and randomized study using ribavirin as monotherapy for the treatment of naïve patients with chronic hepatitis C.
    Felipe M; Silva AE; Lopes EP; Figueiredo VM; Cruz CN; Oliveira PM; Granero L; Lanzoni V; Ferraz LG
    Braz J Infect Dis; 2000 Aug; 4(4):183-91. PubMed ID: 11008222
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.